nps-568 has been researched along with exenatide in 1 studies
Studies (nps-568) | Trials (nps-568) | Recent Studies (post-2010) (nps-568) | Studies (exenatide) | Trials (exenatide) | Recent Studies (post-2010) (exenatide) |
---|---|---|---|---|---|
162 | 4 | 54 | 2,806 | 383 | 2,016 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bowe, JE; Chander, A; Jones, PM; Liu, B; Persaud, SJ | 1 |
1 other study(ies) available for nps-568 and exenatide
Article | Year |
---|---|
The permissive effects of glucose on receptor-operated potentiation of insulin secretion from mouse islets: a role for ERK1/2 activation and cytoskeletal remodelling.
Topics: Actins; Aniline Compounds; Animals; Blood Glucose; Cytoskeleton; Enzyme Inhibitors; Exenatide; Flavonoids; Glucose; Indoles; Insulin; Insulin Secretion; Islets of Langerhans; Kisspeptins; Male; MAP Kinase Signaling System; Mice; Mice, Inbred ICR; Peptides; Phenethylamines; Phosphorylation; Propylamines; Radioimmunoassay; Venoms | 2013 |